<> <> <> <>

Zepbound vs Mounjaro: What’s the difference for weight loss?

If the same active ingredient is doing the heavy lifting, what actually separates one brand from the other?

Written by Lucinda Starr
Last updated Mar 17, 2026
6 min read
6 References
Zepbound vs Mounjaro: What's the Difference for Weight Loss?
Jump to:
Arrow Bot

Key takeaways

  • Zepbound and Mounjaro contain the same active ingredient — tirzepatide — but are approved for different purposes in Canada: Zepbound for chronic weight management, and Mounjaro for blood sugar control in type 2 diabetes.
  • Because the active ingredient is identical, the biological mechanism and side effect profile are very similar; the key differences come down to approved indication, how insurers categorise each, and what your clinician determines fits your health profile.
  • Women starting either medication should be aware that tirzepatide can affect the absorption of oral contraceptives, and both products carry important contraindications including pregnancy, breastfeeding, and a personal or family history of certain thyroid conditions.

If you’ve landed on “Zepbound vs Mounjaro”, chances are you’ve already noticed the confusing bit: they both contain tirzepatide, and they both get mentioned in the same breath whenever weight loss comes up. So is this a real comparison, or just two labels in a trench coat? [1] The question becomes, if the same active ingredient is doing the heavy lifting, what actually separates one brand from the other when your goal is to lose weight?

What is Zepbound?

Zepbound is a prescription medication that contains tirzepatide and is approved in Canada for chronic weight management [2]. That includes both weight loss and weight maintenance in adults living with obesity, or in adults who are overweight and also have at least one weight-related health condition such as high blood pressure, high cholesterol, type 2 diabetes, or obstructive sleep apnea.

Like other newer weight loss medications, Zepbound works on appetite and fullness signals, helping people feel satisfied sooner and less preoccupied with food all day long [3]. That can support significant weight loss over time, especially when it’s paired with a reduced-calorie diet, movement, and lifestyle changes that are realistic enough to survive a bad week. Which, frankly, is the standard any health plan should be held to.

Is Zepbound available in Canada?

Yes — Zepbound is available in Canada as a regulated prescription product, and it's available through Juniper for eligible patients.

What is Mounjaro?

Mounjaro also contains tirzepatide, which is where the confusion starts and, honestly, where it’s fair enough to start asking questions [4]. It’s the same active ingredient as Zepbound, made by the same company, but in Canada, it’s approved for a different primary purpose: improving blood sugar control in adults with type 2 diabetes. So while Zepbound and Mounjaro are built from the same molecule, they aren’t positioned in exactly the same way when it comes to treatment goals.

Is Mounjaro available in Canada?

Yes — Mounjaro is available in Canada as a prescription tirzepatide product, also available through Juniper, meaning eligible patients can access it through a medically guided pathway with consistent support.

What are the key differences between Zepbound and Mounjaro?

This is where the plot twist turns out to be less dramatic than the marketing suggests. Zepbound vs Mounjaro is mostly a question of approval, intended use, access, and insurance, rather than one medication secretly being the “better” tirzepatide in a nicer outfit.

Zepbound [3] Mounjaro [5]
Active ingredient Tirzepatide Tirzepatide
Main approved use in Canada Chronic weight management, including weight loss and weight maintenance Improve glycaemic control in adults with type 2 diabetes
Who it's generally prescribed for Adults with obesity, or overweight adults with a weight-related health condition such as high blood pressure, high cholesterol, or obstructive sleep apnea Adults with type 2 diabetes who need better blood sugar control
How it's taken Once-weekly tirzepatide injection Once-weekly tirzepatide injection
Big-picture difference Built and branded as an obesity treatment Built and branded as a diabetes treatment that may also affect body weight

Effectiveness for weight loss

When it comes to weight loss, the crucial thing to understand is that Zepbound and Mounjaro contain the same active ingredient, so the biological engine underneath is the same. Tirzepatide works on appetite and fullness pathways, helping many people eat less, feel satisfied sooner, and see meaningful changes in body weight over time [6]. So if you’re wondering whether one somehow contains more magic than the other, not quite. In practical terms, the difference is less about the molecule and more about how it’s being prescribed, what it’s officially intended to treat, and whether your healthcare provider thinks it fits your treatment goals.

Approval and intended use

This is the main difference, and it matters more than the box design. In Canada, Zepbound is indicated for chronic weight management in adults living with obesity or in adults who are overweight and have at least one weight-related condition [2]. Mounjaro, by contrast, is indicated to improve glycaemic control in adults with type 2 diabetes [4]. So while both medications may help people lose weight, only one is positioned here as a dedicated obesity treatment.

Dosing and administration

Both medications are taken as a once-weekly tirzepatide injection, and both are titrated through different doses over time rather than going straight to the maximum dose on day one, which would be a slightly rude introduction for your stomach. In Canada, Zepbound is supplied as a KwikPen containing four weekly doses, while Mounjaro is available in more than one presentation, including KwikPen and marketed single-dose vial formats [4]. So the routine is broadly similar, but the exact delivery setup is not completely identical.

Side effects and safety

Because they use the same tirzepatide ingredient, the side effects and safety profile are also very similar. Common issues are largely gastrointestinal, including abdominal pain, stomach pain, nausea, vomiting, diarrhea, constipation, and decreased appetite. More serious risks include low blood sugar when tirzepatide is used with certain diabetes medicines, serious allergic reactions, severe stomach symptoms that need immediate medical attention, and important warnings around thyroid C-cell tumours, medullary thyroid carcinoma, and multiple endocrine neoplasia syndrome type 2 in people with a relevant personal or family history. [6]

Cost and insurance coverage

This is where things can get annoyingly practical. Even though the two brands contain the same drug, out of pocket cost and insurance coverage may look quite different because insurers usually care about the approved indication, not just the ingredient. In Canada, Lilly’s patient support pages for both brands say financial assistance and reimbursement navigation may be available, but what your health insurance covers will depend on your plan, your diagnosis, and whether the medication is being used for diabetes or weight management.

Are Zepbound and Mounjaro the same medication?

Not exactly, but they are very close relatives. Both Zepbound and Mounjaro contain tirzepatide, so the active ingredient doing the metabolic heavy lifting is the same; the real difference is how each brand is approved and positioned in Canada, with Zepbound indicated for chronic weight management and Mounjaro indicated to improve glycaemic control in adults with type 2 diabetes.

Which is better for weight loss?

If weight loss is the main goal, Zepbound is usually the more straightforward fit on paper because it is specifically approved in Canada for weight loss and weight maintenance in eligible adults. That does not mean Mounjaro cannot help people lose weight  (it can, because it uses the same tirzepatide molecule), but when your clinician is deciding between Zepbound or Mounjaro, the approved indication, your health profile, and your access or insurance coverage all come into play.

What should women know before starting tirzepatide?

First, tirzepatide is not a “start now, sort details later” kind of medication. Before you begin, your healthcare provider should review your medical history, any other medications you take, and whether you have specific risk factors such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Tirzepatide products also carry warnings around thyroid C-cell tumours, and they are contraindicated during pregnancy or breastfeeding, so this is one of those moments where honesty with your clinician is not just helpful, it is the whole game.

Second, women should know that tirzepatide can affect more than appetite. It may change how oral hormonal contraceptives are absorbed, which is why the Canadian product information advises switching to a non-oral contraceptive method, or adding a barrier method, for four weeks after starting treatment and for four weeks after each dose increase [1]. It is also worth flagging that low blood sugar risk can rise when tirzepatide is used with certain diabetes medicines, and symptoms like severe abdominal pain, persistent vomiting, or signs of an allergic reaction need immediate medical attention [6]. Not to be dramatic, but this is very much a “read the leaflet and answer your messages from your clinician” situation.

A holistic, medically guided approach to weight loss with Juniper

The truth is, choosing between weight loss drugs is rarely just about the molecule. What works best can vary from person to person, which is why Juniper's healthcare team helps match women to the medication and plan that suits their goals and needs. The Juniper Program also offers clinical support for dose adjustments and side-effect management, plus practical extras like injection reminders and delivery, which makes the process feel less like a solo mission and more like having very organized people in your corner. Ready to find out if Juniper is right for you? Take the online assessment.

Image credit: Pexels

Questions about medicated weight loss?
Not sure if weight loss medication is right for you? Concerned about side effects? Our team will explain how Juniper works and what to expect - so you can make the best choice for your health.
Book a free call today
Juniper patients lose an average of
23%
body weight
in 1 year
Data sourced from 373,000 weight tracker entries in the Juniper app
Drag the slider below to input your start weight
80lbs
In one year patients at this start weight will be:
14lbs
Discover your options
Discover if weight loss medication is right for you
  1. No GP referral
  2. Ongoing expert support
  3. Trusted by 260,000 members worldwide
 
Caroline
15kg in 3.5 months

“I was always on this yo-yo diet scenario, which never worked. I always just felt hungry throughout the dieting process and it actually kinda gets you down”

See the results for yourself
Caroline
15kg in 3.5 months
Carol Malone
25kg

“Juniper has been my weight loss miracle, we all need help on our weight loss journey, especially because it gets harder the longer it goes on.”

See the results for yourself
Carol Malone
25kg
Sarah
11kg in 3 months
Sarah
11kg

“Juniper's just given me my confidence back. That's what my friends are saying, “You've got your smile back, you've got your sparkle back,” which I know I'd lost.”

See the results for yourself
References
See all